CLF episode 20261019_CLF_MIDDAY
Public episode JSON embedded as readable text for automated access.
{
"schema_version": "tryding-agent-episode.v1",
"episode_id": "20261019_CLF_MIDDAY",
"episode_url": "https://trydingday.com/data/agents/v1/episodes/20261019_CLF_MIDDAY.html",
"public_page_url": "https://trydingday.com/coverage/clf/2026-10-19/midday/",
"published_at": "2026-10-19T18:14:42.286505Z",
"updated_at": "2026-10-23T22:04:24.201733Z",
"lifecycle": {
"tracking_status": "open",
"active_for_tracking": true,
"stage": "tracking"
},
"instrument": {
"type": "equity",
"symbol": "CLF",
"exchange": "NYSE",
"name": "Cleveland-Cliffs Inc."
},
"technical_reference": {
"status": "ok",
"reference_price": 13.93,
"model_downside_reference": 12.71,
"model_upside_scenario_1": 15.14,
"model_upside_scenario_2": 16.36,
"atr_14": 0.81,
"method": "reference_price_plus_minus_atr14"
},
"public_content": {
"date": "October 19, 2026",
"generated_at": "2026-10-19T18:14:42.286505Z",
"original_published_at": null,
"session_tag": "midday",
"label": "Market coverage",
"try_label": "Raw Try",
"public_status": "Raw Try",
"why_today": "Sealed news coverage describes Cleveland-Cliffs' strongest quarter in three years while also noting a revenue miss. The captured move had strong participation and relative performance, but the same-day SEC filing's contents are not summarized in the packet. This is a focused research thesis, not a confirmed 15-session path.",
"entry_reasoning": "Panel thesis: Sealed news coverage describes Cleveland-Cliffs' strongest quarter in three years, while also noting a revenue miss. If the company filing supports the reported operating story and the stock maintains its relative strength, CLF has a useful, testable 15-session research thesis. The evidence does not establish that path today. Invalidation boundary: The company filing fails to support the reported operating story, or subsequent provider captures show CLF closing below its supplied prior regular close of $12.12 while losing its relative strength against XLB.",
"reference_price": 13.93,
"scanner": {
"price": 13.93,
"reference": 13.93,
"score": 5,
"score_version": "v0_legacy_reconstructed",
"change": 14.93,
"volume": 33361401,
"average_volume": 18849264,
"volume_ratio": 1.77,
"rsi": 77.53,
"ema_trend": "12.65 > 12.36 > 12.17",
"position_52w": 83.5,
"atr_14": 0.81,
"vwap": 13.62,
"vwap_state": "above",
"vwap_distance_pct": 2.28,
"vwap_reading": {
"price": 13.62,
"state": "above",
"distance_pct": 2.28
},
"range_position": 0.613,
"gap_pct": 0.0,
"relative_strength": {
"excess_pct": 14.2,
"index": "SPY",
"index_chg_pct": 0.73,
"status": "normal"
},
"volume_percentile": {
"median_vol": 16362000,
"percentile": 92.2,
"status": "exceptional",
"today_vol": 33361401
},
"extension": {
"atr": 0.81,
"dist_atr": 1.94,
"ema_ref": 12.36,
"status": "healthy"
},
"atr_move_signal": {
"atr_pct": 5.81,
"status": "strong",
"z": 2.57
},
"sector_breadth": {
"chg_pct": 0.07,
"etf": "XLB",
"status": "neutral"
},
"sentiment": null,
"sentiment_score": null,
"earnings_warning": {
"days_away": 0,
"earnings_date": "2026-10-19",
"has_earnings_soon": true,
"status": "earnings_day"
},
"options_snapshot": null,
"extended_hours": {
"ext_pct": null,
"market_state": "REGULAR",
"phase": "regular",
"post_market_pct": null,
"pre_market_pct": null,
"status": "none"
},
"coiled_spring": {
"component_count": 0,
"components": {},
"count": 0,
"detector_version": "coiled-compression-ohlc.v1",
"reason": "coiled_ohlc_detector_runs_on_research_and_known_ticker_rails",
"schema_version": "coiled-features.v2",
"status": "not_evaluated"
},
"short_pct_float": 13.89,
"days_to_cover": 5.64,
"catalyst": "Cleveland-Cliffs Jumps 10% on Strongest Quarter in Three Years; Nucor and Steel Dynamics Edge Higher",
"sector": "Basic Materials",
"exchange": "NYSE",
"sec_signal": "GRANT_ONLY (A)"
},
"levels": {
"reference": 13.93,
"downside": 12.71,
"upside_1": 15.14,
"upside_2": 16.36
},
"review": {
"score": 5,
"status": "Raw Try",
"summary": "Sealed news coverage describes Cleveland-Cliffs' strongest quarter in three years while also noting a revenue miss. The captured move had strong participation and relative performance, but the same-day SEC filing's contents are not summarized in the packet. This is a focused research thesis, not a confirmed 15-session path.",
"views": [
{
"name": "Marcus Feld",
"role": "information, fundamentals and catalyst analyst",
"icon": "🦊",
"view": "Before the names: the last complete index snapshot had the S&P 500, Nasdaq 100 and Russell 2000 higher, but it was already stale at this decision cutoff. The separate breadth sample—how many stocks rose versus fell—had more decliners, so the index gains were not broadly shared. The gasoline CPI and AI-credit stories are day context, not company catalysts.",
"reasoning": "I support Raw Try. We have a specific reported earnings event, observable participation and relative performance, plus a filing and a falsifier to check. The 15-session path remains unproven, so this is not Try of the Day. The decision is Raw Try by majority, with Elena's explicit Catch dissent."
},
{
"name": "Nate Brooks",
"role": "market structure and timing analyst",
"icon": "📈",
"view": "CLF's captured change was 15.06% on 1.77 times average volume, and the later provider series ended at +16.25%. Its supplied 20-session return beat the XLB sector proxy by 14.59 percentage points. The capture was above VWAP, the volume-weighted average price; that means the price was above the session's average traded price after weighting busier periods more heavily. It supports today's structure, not a 15-session promise. I support Raw Try, not Try of the Day.",
"reasoning": ""
},
{
"name": "Elena Vartanyan",
"role": "independent statistical auditor",
"icon": "🎯",
"view": "I vote Caught: No Try. The revenue account conflicts, the filing detail is absent, and one session cannot show that the operating story will persist. CLF's active 15-session model output is 48.59% for a positive return; its modeled return range runs from -21.93% at P10 to +21.40% at P90. That is a wide, uncertain range, not a reason to publish a Try.",
"reasoning": ""
},
{
"name": "Kenji Osei",
"role": "AI Systems & Market Data Integrity Analyst",
"icon": "🧠",
"view": "The filing record confirms that an 8-K exists, not what it says. That leaves a precise document check: see whether the filing supports the reported quarter and outlook. I support Raw Try because that check can confirm or falsify a useful thesis without presenting the report as verified fact.",
"reasoning": ""
},
{
"name": "Priya Nandakumar",
"role": "institutional risk and execution manager",
"icon": "🛡️",
"view": "CLF sits 1.94 ATR above its EMA reference. ATR is a measure of a stock's recent typical daily price range; nearly two such ranges above the reference means a sharp pullback could erase a meaningful part of this move. That risk rules out Try of the Day for me. The filing check and a relative-performance follow-up are concrete enough for Raw Try.",
"reasoning": ""
}
],
"conviction": {
"status_phrase": "recorded",
"basis": "Support — CLF has a specific reported event, a filing to inspect and the strongest supplied combination of participation and relative performance. Counter-case — the revenue account conflicts and the filing contents are not summarized, so Catch remains a credible view. Unresolved — the next provider observations and company filing detail are still pending.",
"risk": "",
"resolution_pct": 65.0,
"counter_case_pct": 20.0,
"unresolved_pct": 15.0
},
"context_roundtable": {
"mode": "coffee",
"status": "complete",
"consulted_voice_ids": [
"elena",
"marcus",
"kenji",
"priya",
"nate"
],
"summary": "The Coffee read October 19 as a day of crosscurrents: the dated market snapshot showed benchmark gains and lower VIX, while an earlier complete breadth proxy showed more decliners than advancers. Gasoline inflation and reporting on AI financing and returns added separate cost and credit questions. Those conditions frame the already sealed CLF case; they do not change its Raw Try resolution.",
"long_read": "The discussion began with the day-wide context. BLS reported gasoline prices 34.2% higher year over year through September, while Reuters and CNBC reporting in the supplied public cut described scrutiny of AI spending returns and credit stress around the AI bull case. Those are separate macro and financing signals. They do not establish a company-specific cost change for Cleveland-Cliffs.\n\nThe shared market snapshot was captured at 16:54 UTC and was complete across its seven rows at capture. At the effective decision cutoff, about 26 minutes later, it was beyond its stated 360-second freshness interval. Its benchmark changes were positive, while the separate Finnhub breadth proxy captured at 16:35 UTC had complete fresh-quote coverage and more decliners than advancers. The EOD breadth layer was unavailable. The two readings refer to different captures and scopes, so the exchange treated them as context with a timing boundary rather than a single synchronized market signal.\n\nThe company-specific bridge remained narrow. Cleveland-Cliffs says its Toledo direct-reduction plant uses natural gas and iron-ore pellets to make HBI. The BLS gasoline series measures consumer gasoline prices; it does not quantify the plant’s natural-gas bill, freight costs or steel margins. Likewise, reports about AI financing and data-center returns describe a broader credit and investment debate, not a demonstrated CLF financing event. The Coffee kept those macro channels as background for the existing publication and left its sealed Raw Try decision unchanged.",
"transcript": [
{
"speaker_id": "elena",
"text": "The day carries two different pressures in the public cut. BLS reported gasoline prices up 34.2% year over year through September, while Reuters described investors asking for clearer returns on AI spending. One is a consumer-energy inflation signal; the other is scrutiny of capital spending and its financing.",
"source_urls": [
"https://x.com/ReutersBiz/status/2112144229342360028"
]
},
{
"speaker_id": "marcus",
"text": "There is a practical steel-industry connection to energy, though the data bridge is narrow. Cleveland-Cliffs says its Toledo direct-reduction plant uses natural gas and iron-ore pellets to produce hot-briquetted iron, a metallic feedstock for steelmaking. That describes an input channel; it does not quantify the company’s fuel costs."
},
{
"speaker_id": "nate",
"text": "The later market snapshot showed the major benchmarks higher. Does the earlier breadth reading mean the market was moving in opposite directions?"
},
{
"speaker_id": "kenji",
"text": "Breadth is a count of how many shares rose compared with how many fell. The earlier quote proxy had more decliners than advancers; the later index snapshot was firmer. Different capture times and different groups of securities can produce both readings without a data contradiction."
},
{
"speaker_id": "elena",
"text": "That makes the market signal less uniform than the headline index direction suggests. The snapshot at 16:54 UTC showed the S&P 500 up 0.55%, the Nasdaq 100 up 1.43% and the Russell 2000 up 0.48%. Those are changes from prior levels, not index levels, and the capture was stale by the decision cutoff."
},
{
"speaker_id": "nate",
"text": "The VIX row adds another dimension: its level was 18.12 and its change was down 9.35%. The VIX is an options-based gauge of expected near-term market swings; a lower reading describes volatility pricing, while direction and participation come from other observations."
},
{
"speaker_id": "priya",
"text": "CNBC flagged credit stress as a risk to the AI bull case, and Axios described debt financing as one pressure point in the data-center buildout. That makes financing terms relevant to the broader market conversation. The reports identify a risk channel; they do not establish a market-wide credit event.",
"source_urls": [
"https://x.com/CNBC/status/2112149842336112920"
]
},
{
"speaker_id": "marcus",
"text": "The gasoline CPI series is a retail motor-fuel measure. It cannot be used as a proxy for the natural-gas price paid by an industrial plant or for Cleveland-Cliffs’ freight bill. The company’s own cost disclosures would be needed to connect energy prices to its steel economics."
},
{
"speaker_id": "elena",
"text": "The Treasury row is also a level-and-change pair: the 10-year yield was 5.144%, with a reported increase of 4.60 basis points. A basis point is 0.01 percentage point, so it describes a small move in the benchmark yield; it does not give a company’s borrowing rate."
},
{
"speaker_id": "priya",
"text": "That distinction matters because a corporate borrower’s cost also reflects its own credit spread, the extra yield lenders demand over a government benchmark. The supplied market cut has no CLF-specific spread. We can discuss financing sensitivity as a channel without pricing it for this company."
},
{
"speaker_id": "kenji",
"text": "The index snapshot was complete when captured, and its age matters to how it is used: it exceeded the stated six-minute freshness interval by the effective cutoff. The earlier breadth proxy was separately complete at its own timestamp, while the end-of-day breadth layer was unavailable. Coverage at capture and freshness at cutoff answer different questions."
},
{
"speaker_id": "marcus",
"text": "Cleveland-Cliffs describes integration from mining and raw-material production through steelmaking and downstream stamping and tubing. That structure may affect how the company manages material supply. Energy, demand and financing still need their own evidence before we connect them to company results."
},
{
"speaker_id": "elena",
"text": "So the day’s broad picture combines an inflation concern, questions about credit and investment returns, positive benchmark changes in a dated snapshot, and mixed participation in an earlier proxy. For readers of the CLF publication, those forces are context around the company evidence; the conversation leaves the sealed decision intact.",
"source_urls": [
"https://x.com/CNBC/status/2112149842336112920",
"https://x.com/ReutersBiz/status/2112144229342360028"
]
}
],
"source_urls": [
"https://x.com/ReutersBiz/status/2112144229342360028",
"https://x.com/CNBC/status/2112149842336112920"
]
},
"context_roundtable_sources": [
{
"event_id": "mi_evt_d1b724a7445761294a3dc315",
"headline": "CNBC flags credit stress as a risk to the AI bull case",
"url": "https://x.com/CNBC/status/2112149842336112920",
"publisher": "CNBC",
"source_quality": "trusted_reporting",
"public_safe": true,
"published_at": "2026-10-19T11:52:18Z",
"available_at": "2026-10-19T15:51:27+00:00"
},
{
"event_id": "mi_evt_e3348526031e33d8a1783fb6",
"headline": "Investors seek clearer returns on AI spending as data-center economics face scrutiny",
"url": "https://x.com/ReutersBiz/status/2112144229342360028",
"publisher": "Reuters",
"source_quality": "trusted_reporting",
"public_safe": true,
"published_at": "2026-10-19T11:30:00Z",
"available_at": "2026-10-19T15:51:27+00:00"
}
]
},
"updates": [
{
"day": 4,
"timestamp": "2026-10-23T22:04:24.201733Z",
"date": "Session 4 · Oct 23, 2026 · 18:04 NYSE",
"text": "The tracked loss widened 0.36 points to 0.57% on session 4 even as the latest capture rose 6.51% to $13.90 above VWAP. CLF remains 11.09 points ahead of Basic Materials over 20 sessions; this keeps the market response constructive, but the package still does not verify the reported quarterly results or resolve the revenue miss from the filing.",
"price": 13.9,
"pct": -0.57,
"return_vs_entry_pct": -0.22,
"return_vs_base_pct": -0.22,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.72,
"session_day": 4,
"reference_price": 13.93,
"reference_text": "$13.90 · -0.22% from $13.93 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-23T21:24:41Z",
"vwap_as_of": null
},
{
"day": 4,
"timestamp": "2026-10-23T19:56:02.629117Z",
"date": "Session 4 · Oct 23, 2026 · 15:56 NYSE",
"text": "The tracked CLF loss narrowed 3.94 points to 0.21% on session 4 as shares rose 7.28% to $14.00, above the session average near the range high on roughly average volume; price remains above the $12.12 reference. The rebound improves the market case, but this handoff lacks a current XLB comparison and the revenue-miss question remains unresolved, so it strengthens follow-through without settling the full thesis.",
"price": 14.0,
"pct": -0.21,
"return_vs_entry_pct": 0.5,
"return_vs_base_pct": 0.5,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 4.23,
"session_day": 4,
"reference_price": 13.93,
"reference_text": "$14.00 · +0.50% from $13.93 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": true,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-61adf8f4a715019efe90fb7fd498077162a9de7bf6fd7139b3bc3bba0c16c991",
"price_as_of": "2026-10-23T19:22:12.987963Z",
"vwap_as_of": null
},
{
"day": 4,
"timestamp": "2026-10-23T14:58:24.560289Z",
"date": "Session 4 · Oct 23, 2026 · 10:58 NYSE",
"text": "The tracked loss narrowed 2.50 points to 4.15% on session 4 as shares rebounded 2.76% to $13.41 above the session average, though activity was only 0.23 times the usual pace. The 20-session lead over Basic Materials widened to 7.31 points and price remains above $12.12; the Q3 operating story is still qualified by the revenue miss, so this move improves follow-through without confirming the thesis.",
"price": 13.41,
"pct": -4.15,
"return_vs_entry_pct": -3.73,
"return_vs_base_pct": -3.73,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 2.59,
"session_day": 4,
"reference_price": 13.93,
"reference_text": "$13.41 · -3.73% from $13.93 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-23T14:06:04.621810Z",
"vwap_as_of": null
},
{
"day": 3,
"timestamp": "2026-10-22T22:04:48.411836Z",
"date": "Session 3 · Oct 22, 2026 · 18:04 NYSE",
"text": "The tracked loss deepened 1.71 points to 6.65% on session 3 as shares fell 6.99% to $13.05 below VWAP near the low on 1.73 times average volume. Price remains above the $12.12 reference and just 0.35 points ahead of Basic Materials over twenty sessions. The Q3 EBITDA result is supportive, but this reversal weakens market follow-through.",
"price": 13.05,
"pct": -6.65,
"return_vs_entry_pct": -6.32,
"return_vs_base_pct": -6.32,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -1.4,
"session_day": 3,
"reference_price": 13.93,
"reference_text": "$13.05 · -6.32% from $13.93 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-22T21:20:41Z",
"vwap_as_of": null
},
{
"day": 3,
"timestamp": "2026-10-22T19:46:04.050191Z",
"date": "Session 3 · Oct 22, 2026 · 15:46 NYSE",
"text": "CLF lost 5.30 points to a 4.94% tracked loss on session 3; shares fell 5.60% to $13.245 below VWAP near the session low on 1.28 times average volume. Price remains above the $12.12 reference and the 20-session lead over Basic Materials is still 2.21 points, so the published invalidation test is not met. The October 19 filing supports Q3 EBITDA above guidance, but today's reversal weakens market follow-through. Model same-direction probability is 45.8% through session 15 in a wide range; durability remains unresolved.",
"price": 13.245,
"pct": -4.94,
"return_vs_entry_pct": -4.92,
"return_vs_base_pct": -4.92,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -5.64,
"session_day": 3,
"reference_price": 13.93,
"reference_text": "$13.24 · -4.92% from $13.93 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-30791c6b3ab5d780fc7d20183f530ae2c5d6c17652bf23b641e656ea7064ac6d",
"price_as_of": "2026-10-22T19:21:50.306215Z",
"vwap_as_of": null
},
{
"day": 2,
"timestamp": "2026-10-21T21:52:37.216082Z",
"date": "Session 2 · Oct 21, 2026 · 17:52 NYSE",
"text": "CLF added 2.72 points to its tracked return, reaching +0.36% on session 2. The latest quote rose 2.78% to $14.03 and stayed above VWAP near the range high, with activity accelerating. Its twenty-session lead over Basic Materials is 6.94 points. The prior report of Q3 adjusted EBITDA above guidance and a stronger Q4 outlook remains the thesis, but this handoff adds no filing detail and two sessions do not establish durability.",
"price": 14.03,
"pct": 0.36,
"return_vs_entry_pct": 0.72,
"return_vs_base_pct": 0.72,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 2.73,
"session_day": 2,
"reference_price": 13.93,
"reference_text": "$14.03 · +0.72% from $13.93 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-21T20:37:07Z",
"vwap_as_of": null
},
{
"day": 2,
"timestamp": "2026-10-21T00:36:39.998481Z",
"date": "Session 2 · Oct 20, 2026 · 20:36 NYSE",
"text": "CLF's tracked result stayed at -2.36% on session 2; shares fell 3.19% to $13.65 on 2.19 times average volume but held 2.59% above VWAP. The prior update reported $612 million in Q3 adjusted EBITDA against $575 million guidance and about $715 million expected in Q4; the current packet does not reproduce the filing text, so this one-session path remains too short to confirm that operating story.",
"price": 13.65,
"pct": -2.36,
"return_vs_entry_pct": -2.01,
"return_vs_base_pct": -2.01,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -0.97,
"session_day": 2,
"reference_price": 13.93,
"reference_text": "$13.65 · -2.01% from $13.93 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-20T23:08:59Z",
"vwap_as_of": null
},
{
"day": 1,
"timestamp": "2026-10-20T21:30:05.928773Z",
"date": "Session 1 · Oct 20, 2026 · 17:30 NYSE",
"text": "CLF’s tracked gain from its episode reference fell 3.22 points to −2.36% on session 1; shares eased 2.23% to $13.79 but remained 2.59% above VWAP on 1.52 time-adjusted volume. The Oct. 19 filing confirms Q3 adjusted EBITDA of $612m versus $575m guidance, $5.6bn revenue and $165m net income; management expects about $715m Q4 adjusted EBITDA. Price stays above $12.12, but current XLB-relative data are unavailable and the post-earnings path is only one session old.",
"price": 13.785,
"pct": -2.36,
"return_vs_entry_pct": -1.04,
"return_vs_base_pct": -1.04,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -2.26,
"session_day": 1,
"reference_price": 13.93,
"reference_text": "$13.79 · -1.04% from $13.93 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-35d4917169184fcd208fcf05cf9da19482c42365e413b0f25338df8a40ccb7b2",
"price_as_of": "2026-10-20T19:32:17.054310Z",
"vwap_as_of": null
},
{
"day": 0,
"timestamp": "2026-10-19T22:20:35.598272Z",
"date": "Session 0 · Oct 19, 2026 · 18:20 NYSE",
"text": "CLF's tracked gain from the episode reference slipped 2.27 percentage points to 0.86%, even as price surged 16.34% from the prior close on 4.69 times normal volume and held 3.42% above VWAP. Its 20-session excess over XLB remains 14.33 points, but the evidence still lacks filing detail to verify the reported earnings story.",
"price": 14.1,
"pct": 0.86,
"return_vs_entry_pct": 1.22,
"return_vs_base_pct": 1.22,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": -1.76,
"session_day": 0,
"reference_price": 13.93,
"reference_text": "$14.10 · +1.22% from $13.93 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": false,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "",
"price_as_of": "2026-10-19T21:29:42Z",
"vwap_as_of": null
},
{
"day": 0,
"timestamp": "2026-10-19T19:41:44.877339Z",
"date": "Session 0 · Oct 19, 2026 · 15:41 NYSE",
"text": "CLF's tracked return rose 3.13 points from the initial-review baseline; the stock gained 18.36% against the prior regular close and leads XLB by 16.29 points over 20 sessions. It traded 3.42% above its volume-weighted average price on 3.7 times normal volume, but sits more than twice its typical daily range above trend. The handoff lists the 8-K without its contents and has no current-session model reading, so the earnings support and 15-session persistence remain unverified; price is still above $12.12 with relative strength intact.",
"price": 14.345,
"pct": 3.13,
"return_vs_entry_pct": 2.98,
"return_vs_base_pct": 2.98,
"return_vs_prior_pct": null,
"previous_regular_close": null,
"change_vs_prior_session_pct": 2.98,
"session_day": 0,
"reference_price": 13.93,
"reference_text": "$14.35 · +2.98% from $13.93 base",
"timing": "",
"market_marker": null,
"extended_hours": null,
"relevant": true,
"active_relevant": false,
"terminal_closure": false,
"transcript_anchor": "transcript-entry-80cec71238a346d6e262071cc81ebeac88e8e87e5660c9e2b1eb941630576221",
"price_as_of": "2026-10-19T19:21:30.182691Z",
"vwap_as_of": null
}
],
"observed_outcomes": [
{
"label": "+1 sessions",
"status": "complete",
"return": -2.36,
"reference_text": "-2.36% from $13.93 base",
"price": 13.65,
"updated": "Oct 20, 2026 · 17:17 NYSE",
"mfe": -1.04,
"mae": -9.69
},
{
"label": "+5 sessions",
"status": "pending",
"return": null,
"reference_text": "",
"price": null,
"updated": "",
"mfe": null,
"mae": null
},
{
"label": "+10 sessions",
"status": "pending",
"return": null,
"reference_text": "",
"price": null,
"updated": "",
"mfe": null,
"mae": null
},
{
"label": "+15 sessions",
"status": "pending",
"return": null,
"reference_text": "",
"price": null,
"updated": "",
"mfe": null,
"mae": null
}
],
"candidate_comparison_history": [
{
"day": 0,
"timestamp": "2026-10-19T19:41:44.877339Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-19T19:41:44.877339Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CLF",
"role": "selected",
"price": 14.345,
"base_price": 13.93,
"return_since_base_pct": 2.9792,
"session_return_pct": 18.36,
"change_since_prior_pct": 0.3498,
"volume_ratio": 3.7,
"rsi": 79.08,
"vwap": 13.87,
"vwap_distance_pct": 3.4247,
"position_52w_pct": 85.9,
"extended_hours_pct": null,
"as_of": "2026-10-19T19:21:30.182691Z",
"source": "yfinance_quote",
"name": "Cleveland-Cliffs Inc.",
"episode_id": "n0:CLF:2026-10-19",
"ema_trend": "12.73 > 12.39 > 12.04",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:17:00.453928Z",
"facts": [
"The sealed news item describes the quarter as the strongest in three years and also notes a revenue miss.",
"The supplied quote snapshot records a $13.945 price and a +15.06% change against the $12.12 previous regular close; volume was 1.77 times its three-month average.",
"The later provider series ended at a +16.254128% return. The supplied 20-session comparison reports +16.94% for CLF, +2.35% for XLB and +14.59 percentage points of excess return versus XLB.",
"A same-day SEC 8-K record is present, but its contents are not summarized in the sealed packet."
],
"price_as_of": "2026-10-19T19:21:30.182691Z",
"vwap_as_of": null
},
{
"symbol": "MRKR",
"role": "alternative",
"price": 1.135,
"base_price": 1.1,
"return_since_base_pct": 3.1818,
"session_return_pct": 9.1346,
"change_since_prior_pct": 1.3393,
"volume_ratio": 4.6,
"rsi": 50.0,
"vwap": 1.11,
"vwap_distance_pct": 2.2523,
"position_52w_pct": 44.72,
"extended_hours_pct": null,
"as_of": "2026-10-19T19:21:49Z",
"source": "yfinance_quote",
"name": "Marker Therapeutics, Inc.",
"episode_id": "n0:MRKR:2026-10-19",
"ema_trend": "1.01 > 1.05 > 1.12",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:15:55.926875Z",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"price_as_of": "2026-10-19T19:21:49Z",
"vwap_as_of": null
},
{
"symbol": "ATNM",
"role": "alternative",
"price": 1.34,
"base_price": 1.3501,
"return_since_base_pct": -0.7481,
"session_return_pct": 18.75,
"change_since_prior_pct": 0.7519,
"volume_ratio": 1.99,
"rsi": 63.82,
"vwap": 1.29,
"vwap_distance_pct": 3.876,
"position_52w_pct": 77.59,
"extended_hours_pct": null,
"as_of": "2026-10-19T19:23:33Z",
"source": "yfinance_quote",
"name": "Actinium Pharmaceuticals, Inc.",
"episode_id": "n0:ATNM:2026-10-19",
"ema_trend": "1.13 > 1.13 > 1.09",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:16:17.856663Z",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"price_as_of": "2026-10-19T19:23:33Z",
"vwap_as_of": null
},
{
"symbol": "INFY",
"role": "alternative",
"price": 12.25,
"base_price": 12.275,
"return_since_base_pct": -0.2037,
"session_return_pct": 0.0817,
"change_since_prior_pct": 0.1635,
"volume_ratio": 0.48,
"rsi": 75.27,
"vwap": 12.15,
"vwap_distance_pct": 0.823,
"position_52w_pct": 40.92,
"extended_hours_pct": null,
"as_of": "2026-10-19T19:24:50Z",
"source": "yfinance_quote",
"name": "Infosys Limited",
"episode_id": "narrative:INFY:40115d2cb35fa2f1",
"ema_trend": "11.6 > 11.3 > 11.37",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:40Z",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"price_as_of": "2026-10-19T19:24:50Z",
"vwap_as_of": null
},
{
"symbol": "G",
"role": "alternative",
"price": 37.68,
"base_price": 37.68,
"return_since_base_pct": 0.0,
"session_return_pct": 1.1272,
"change_since_prior_pct": -0.3965,
"volume_ratio": 0.15,
"rsi": 78.15,
"vwap": 37.36,
"vwap_distance_pct": 0.8565,
"position_52w_pct": 77.57,
"extended_hours_pct": null,
"as_of": "2026-10-19T19:24:48Z",
"source": "yfinance_quote",
"name": "Genpact Limited",
"episode_id": "narrative:G:62d41fe65f9523e4",
"ema_trend": "35.96 > 35.14 > 34.75",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:30Z",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"price_as_of": "2026-10-19T19:24:48Z",
"vwap_as_of": null
},
{
"symbol": "RIGL",
"role": "alternative",
"price": 46.715,
"base_price": 47.1998,
"return_since_base_pct": -1.0271,
"session_return_pct": 1.6206,
"change_since_prior_pct": 0.3437,
"volume_ratio": 0.19,
"rsi": 43.29,
"vwap": 46.66,
"vwap_distance_pct": 0.1179,
"position_52w_pct": 90.35,
"extended_hours_pct": null,
"as_of": "2026-10-19T19:23:45Z",
"source": "yfinance_quote",
"name": "Rigel Pharmaceuticals, Inc.",
"episode_id": "narrative:RIGL:ca95148af41e4931",
"ema_trend": "47.29 > 47.31 > 45.84",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:45Z",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"price_as_of": "2026-10-19T19:23:45Z",
"vwap_as_of": null
},
{
"symbol": "WDAY",
"role": "alternative",
"price": 194.615,
"base_price": 193.84,
"return_since_base_pct": 0.3998,
"session_return_pct": 1.9946,
"change_since_prior_pct": 0.2163,
"volume_ratio": 0.18,
"rsi": 55.62,
"vwap": 192.67,
"vwap_distance_pct": 1.0095,
"position_52w_pct": 78.33,
"extended_hours_pct": null,
"as_of": "2026-10-19T19:25:00Z",
"source": "yfinance_quote",
"name": "Workday, Inc.",
"episode_id": "narrative:WDAY:15757f112d8d2f99",
"ema_trend": "190.5 > 189.74 > 185.71",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:42Z",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"price_as_of": "2026-10-19T19:25:00Z",
"vwap_as_of": null
},
{
"symbol": "ESLT",
"role": "alternative",
"price": 762.0,
"base_price": 759.42,
"return_since_base_pct": 0.3397,
"session_return_pct": 0.8697,
"change_since_prior_pct": 0.113,
"volume_ratio": 0.57,
"rsi": 63.56,
"vwap": 754.86,
"vwap_distance_pct": 0.9459,
"position_52w_pct": 74.74,
"extended_hours_pct": null,
"as_of": "2026-10-19T19:24:25Z",
"source": "yfinance_quote",
"name": "Elbit Systems Ltd.",
"episode_id": "narrative:ESLT:ae731078c5dd8bf2",
"ema_trend": "716.16 > 710.5 > 728.89",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:44Z",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"price_as_of": "2026-10-19T19:24:25Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 8,
"candidate_prices": 8,
"candidate_technical": 8,
"benchmark_rows": 0
}
}
},
{
"day": 0,
"timestamp": "2026-10-19T22:20:35.598272Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-19T22:20:35.598272Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CLF",
"role": "selected",
"price": 14.14,
"base_price": 13.93,
"return_since_base_pct": 1.5075,
"session_return_pct": 16.34,
"change_since_prior_pct": -1.4291,
"volume_ratio": 4.69,
"rsi": 78.14,
"vwap": 13.87,
"vwap_distance_pct": 1.9466,
"position_52w_pct": 84.4,
"extended_hours_pct": 0.28,
"as_of": "2026-10-19T21:29:42Z",
"source": "sealed_extended_quote",
"name": "Cleveland-Cliffs Inc.",
"episode_id": "n0:CLF:2026-10-19",
"ema_trend": "12.68 > 12.37 > 12.03",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:17:00.453928Z",
"facts": [
"The sealed news item describes the quarter as the strongest in three years and also notes a revenue miss.",
"The supplied quote snapshot records a $13.945 price and a +15.06% change against the $12.12 previous regular close; volume was 1.77 times its three-month average.",
"The later provider series ended at a +16.254128% return. The supplied 20-session comparison reports +16.94% for CLF, +2.35% for XLB and +14.59 percentage points of excess return versus XLB.",
"A same-day SEC 8-K record is present, but its contents are not summarized in the sealed packet."
],
"benchmark_excess_pct": {
"sp500": 15.9315,
"nasdaq100": 15.169,
"russell2000": 16.0854
},
"price_as_of": "2026-10-19T21:29:42Z",
"vwap_as_of": null
},
{
"symbol": "MRKR",
"role": "alternative",
"price": 1.16,
"base_price": 1.1,
"return_since_base_pct": 5.4545,
"session_return_pct": -3.3333,
"change_since_prior_pct": 2.2026,
"volume_ratio": 4.6,
"rsi": 50.0,
"vwap": 1.11,
"vwap_distance_pct": 4.5045,
"position_52w_pct": 44.72,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:29:36Z",
"source": "yfinance_quote",
"name": "Marker Therapeutics, Inc.",
"episode_id": "n0:MRKR:2026-10-19",
"ema_trend": "1.01 > 1.05 > 1.12",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:15:55.926875Z",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"benchmark_excess_pct": {
"sp500": -3.7418,
"nasdaq100": -4.5043,
"russell2000": -3.5879
},
"price_as_of": "2026-10-19T20:29:36Z",
"vwap_as_of": null
},
{
"symbol": "ATNM",
"role": "alternative",
"price": 1.32,
"base_price": 1.3501,
"return_since_base_pct": -2.2295,
"session_return_pct": 19.48,
"change_since_prior_pct": -1.4925,
"volume_ratio": 1.99,
"rsi": 63.82,
"vwap": 1.29,
"vwap_distance_pct": 2.3256,
"position_52w_pct": 77.59,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:56:04Z",
"source": "yfinance_quote",
"name": "Actinium Pharmaceuticals, Inc.",
"episode_id": "n0:ATNM:2026-10-19",
"ema_trend": "1.13 > 1.13 > 1.09",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:16:17.856663Z",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"benchmark_excess_pct": {
"sp500": 19.0715,
"nasdaq100": 18.309,
"russell2000": 19.2254
},
"price_as_of": "2026-10-19T20:56:04Z",
"vwap_as_of": null
},
{
"symbol": "INFY",
"role": "alternative",
"price": 12.2407,
"base_price": 12.275,
"return_since_base_pct": -0.2794,
"session_return_pct": 0.3336,
"change_since_prior_pct": -0.0759,
"volume_ratio": 0.48,
"rsi": 75.27,
"vwap": 12.15,
"vwap_distance_pct": 0.7465,
"position_52w_pct": 40.92,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:55:19Z",
"source": "yfinance_quote",
"name": "Infosys Limited",
"episode_id": "narrative:INFY:40115d2cb35fa2f1",
"ema_trend": "11.6 > 11.3 > 11.37",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:40Z",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"benchmark_excess_pct": {
"sp500": -0.0749,
"nasdaq100": -0.8374,
"russell2000": 0.079
},
"price_as_of": "2026-10-19T20:55:19Z",
"vwap_as_of": null
},
{
"symbol": "G",
"role": "alternative",
"price": 37.68,
"base_price": 37.68,
"return_since_base_pct": 0.0,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.15,
"rsi": 78.15,
"vwap": 37.36,
"vwap_distance_pct": 0.8565,
"position_52w_pct": 77.57,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:00:47Z",
"source": "yfinance_quote",
"name": "Genpact Limited",
"episode_id": "narrative:G:62d41fe65f9523e4",
"ema_trend": "35.96 > 35.14 > 34.75",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:30Z",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"price_as_of": "2026-10-19T21:00:47Z",
"vwap_as_of": null
},
{
"symbol": "RIGL",
"role": "alternative",
"price": 46.72,
"base_price": 47.1998,
"return_since_base_pct": -1.0165,
"session_return_pct": null,
"change_since_prior_pct": 0.0107,
"volume_ratio": 0.19,
"rsi": 43.29,
"vwap": 46.66,
"vwap_distance_pct": 0.1286,
"position_52w_pct": 90.35,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:01Z",
"source": "yfinance_quote",
"name": "Rigel Pharmaceuticals, Inc.",
"episode_id": "narrative:RIGL:ca95148af41e4931",
"ema_trend": "47.29 > 47.31 > 45.84",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:45Z",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"price_as_of": "2026-10-19T20:00:01Z",
"vwap_as_of": null
},
{
"symbol": "WDAY",
"role": "alternative",
"price": 195.2,
"base_price": 193.84,
"return_since_base_pct": 0.7016,
"session_return_pct": null,
"change_since_prior_pct": 0.3006,
"volume_ratio": 0.18,
"rsi": 55.62,
"vwap": 192.67,
"vwap_distance_pct": 1.3131,
"position_52w_pct": 78.33,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:06:04Z",
"source": "yfinance_quote",
"name": "Workday, Inc.",
"episode_id": "narrative:WDAY:15757f112d8d2f99",
"ema_trend": "190.5 > 189.74 > 185.71",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:42Z",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"price_as_of": "2026-10-19T21:06:04Z",
"vwap_as_of": null
},
{
"symbol": "ESLT",
"role": "alternative",
"price": 759.47,
"base_price": 759.42,
"return_since_base_pct": 0.0066,
"session_return_pct": null,
"change_since_prior_pct": -0.332,
"volume_ratio": 0.57,
"rsi": 63.56,
"vwap": 754.86,
"vwap_distance_pct": 0.6107,
"position_52w_pct": 74.74,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:12Z",
"source": "yfinance_quote",
"name": "Elbit Systems Ltd.",
"episode_id": "narrative:ESLT:ae731078c5dd8bf2",
"ema_trend": "716.16 > 710.5 > 728.89",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:44Z",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"price_as_of": "2026-10-19T20:00:12Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7690.73,
"base_price": 7659.44,
"return_since_base_pct": 0.4085,
"session_return_pct": 0.4085,
"as_of": "2026-10-19T22:19:22.795748Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29529.344,
"base_price": 29187.549,
"return_since_base_pct": 1.171,
"session_return_pct": 1.171,
"as_of": "2026-10-19T22:19:22.795748Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2728.298,
"base_price": 2721.37,
"return_since_base_pct": 0.2546,
"session_return_pct": 0.2546,
"as_of": "2026-10-19T22:19:22.795748Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 8,
"candidate_prices": 8,
"candidate_technical": 8,
"benchmark_rows": 3
}
}
},
{
"day": 1,
"timestamp": "2026-10-20T21:30:05.928773Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-20T21:30:05.928773Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CLF",
"role": "selected",
"price": 13.785,
"base_price": 13.93,
"return_since_base_pct": -1.0409,
"session_return_pct": -2.23,
"change_since_prior_pct": -2.5106,
"volume_ratio": 1.72,
"rsi": 73.9,
"vwap": 13.44,
"vwap_distance_pct": 2.567,
"position_52w_pct": 89.1,
"extended_hours_pct": null,
"as_of": "2026-10-20T19:32:17.054310Z",
"source": "yfinance_quote",
"name": "Cleveland-Cliffs Inc.",
"episode_id": "n0:CLF:2026-10-19",
"ema_trend": "12.9 > 12.49 > 12.1",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:17:00.453928Z",
"facts": [
"The sealed news item describes the quarter as the strongest in three years and also notes a revenue miss.",
"The supplied quote snapshot records a $13.945 price and a +15.06% change against the $12.12 previous regular close; volume was 1.77 times its three-month average.",
"The later provider series ended at a +16.254128% return. The supplied 20-session comparison reports +16.94% for CLF, +2.35% for XLB and +14.59 percentage points of excess return versus XLB.",
"A same-day SEC 8-K record is present, but its contents are not summarized in the sealed packet."
],
"benchmark_excess_pct": {
"sp500": -2.514,
"nasdaq100": -2.0977,
"russell2000": -3.8838
},
"price_as_of": "2026-10-20T19:32:17.054310Z",
"vwap_as_of": null
},
{
"symbol": "MRKR",
"role": "alternative",
"price": 1.16,
"base_price": 1.1,
"return_since_base_pct": 5.4545,
"session_return_pct": -3.3333,
"change_since_prior_pct": 0.0,
"volume_ratio": 4.6,
"rsi": 50.0,
"vwap": 1.11,
"vwap_distance_pct": 4.5045,
"position_52w_pct": 44.72,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:29:36Z",
"source": "yfinance_quote",
"name": "Marker Therapeutics, Inc.",
"episode_id": "n0:MRKR:2026-10-19",
"ema_trend": "1.01 > 1.05 > 1.12",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:15:55.926875Z",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"benchmark_excess_pct": {
"sp500": -3.6173,
"nasdaq100": -3.201,
"russell2000": -4.9871
},
"price_as_of": "2026-10-19T20:29:36Z",
"vwap_as_of": null
},
{
"symbol": "ATNM",
"role": "alternative",
"price": 1.32,
"base_price": 1.3501,
"return_since_base_pct": -2.2295,
"session_return_pct": 19.48,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.99,
"rsi": 63.82,
"vwap": 1.29,
"vwap_distance_pct": 2.3256,
"position_52w_pct": 77.59,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:56:04Z",
"source": "yfinance_quote",
"name": "Actinium Pharmaceuticals, Inc.",
"episode_id": "n0:ATNM:2026-10-19",
"ema_trend": "1.13 > 1.13 > 1.09",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:16:17.856663Z",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"benchmark_excess_pct": {
"sp500": 19.196,
"nasdaq100": 19.6123,
"russell2000": 17.8262
},
"price_as_of": "2026-10-19T20:56:04Z",
"vwap_as_of": null
},
{
"symbol": "INFY",
"role": "alternative",
"price": 12.2407,
"base_price": 12.275,
"return_since_base_pct": -0.2794,
"session_return_pct": 0.3336,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": 75.27,
"vwap": 12.15,
"vwap_distance_pct": 0.7465,
"position_52w_pct": 40.92,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:55:19Z",
"source": "yfinance_quote",
"name": "Infosys Limited",
"episode_id": "narrative:INFY:40115d2cb35fa2f1",
"ema_trend": "11.6 > 11.3 > 11.37",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:40Z",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"benchmark_excess_pct": {
"sp500": 0.0496,
"nasdaq100": 0.4659,
"russell2000": -1.3202
},
"price_as_of": "2026-10-19T20:55:19Z",
"vwap_as_of": null
},
{
"symbol": "G",
"role": "alternative",
"price": 37.68,
"base_price": 37.68,
"return_since_base_pct": 0.0,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.15,
"rsi": 78.15,
"vwap": 37.36,
"vwap_distance_pct": 0.8565,
"position_52w_pct": 77.57,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:00:47Z",
"source": "yfinance_quote",
"name": "Genpact Limited",
"episode_id": "narrative:G:62d41fe65f9523e4",
"ema_trend": "35.96 > 35.14 > 34.75",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:30Z",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"price_as_of": "2026-10-19T21:00:47Z",
"vwap_as_of": null
},
{
"symbol": "RIGL",
"role": "alternative",
"price": 46.72,
"base_price": 47.1998,
"return_since_base_pct": -1.0165,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.19,
"rsi": 43.29,
"vwap": 46.66,
"vwap_distance_pct": 0.1286,
"position_52w_pct": 90.35,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:01Z",
"source": "yfinance_quote",
"name": "Rigel Pharmaceuticals, Inc.",
"episode_id": "narrative:RIGL:ca95148af41e4931",
"ema_trend": "47.29 > 47.31 > 45.84",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:45Z",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"price_as_of": "2026-10-19T20:00:01Z",
"vwap_as_of": null
},
{
"symbol": "WDAY",
"role": "alternative",
"price": 195.2,
"base_price": 193.84,
"return_since_base_pct": 0.7016,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.18,
"rsi": 55.62,
"vwap": 192.67,
"vwap_distance_pct": 1.3131,
"position_52w_pct": 78.33,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:06:04Z",
"source": "yfinance_quote",
"name": "Workday, Inc.",
"episode_id": "narrative:WDAY:15757f112d8d2f99",
"ema_trend": "190.5 > 189.74 > 185.71",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:42Z",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"price_as_of": "2026-10-19T21:06:04Z",
"vwap_as_of": null
},
{
"symbol": "ESLT",
"role": "alternative",
"price": 759.47,
"base_price": 759.42,
"return_since_base_pct": 0.0066,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.57,
"rsi": 63.56,
"vwap": 754.86,
"vwap_distance_pct": 0.6107,
"position_52w_pct": 74.74,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:12Z",
"source": "yfinance_quote",
"name": "Elbit Systems Ltd.",
"episode_id": "narrative:ESLT:ae731078c5dd8bf2",
"ema_trend": "716.16 > 710.5 > 728.89",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:44Z",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"price_as_of": "2026-10-19T20:00:12Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7712.57,
"base_price": 7690.73,
"return_since_base_pct": 0.284,
"session_return_pct": 0.284,
"as_of": "2026-10-20T21:29:39.556951Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29490.283,
"base_price": 29529.344,
"return_since_base_pct": -0.1323,
"session_return_pct": -0.1323,
"as_of": "2026-10-20T21:29:39.556951Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2773.4197,
"base_price": 2728.298,
"return_since_base_pct": 1.6538,
"session_return_pct": 1.6538,
"as_of": "2026-10-20T21:29:39.556951Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 8,
"candidate_prices": 8,
"candidate_technical": 8,
"benchmark_rows": 3
}
}
},
{
"day": 2,
"timestamp": "2026-10-21T00:36:39.998481Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-21T00:36:39.998481Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CLF",
"role": "selected",
"price": 13.67,
"base_price": 13.93,
"return_since_base_pct": -1.8665,
"session_return_pct": -3.19,
"change_since_prior_pct": -0.8342,
"volume_ratio": 2.19,
"rsi": 72.22,
"vwap": 13.44,
"vwap_distance_pct": 1.7113,
"position_52w_pct": 88.2,
"extended_hours_pct": 0.15,
"as_of": "2026-10-20T23:08:59Z",
"source": "sealed_extended_quote",
"name": "Cleveland-Cliffs Inc.",
"episode_id": "n0:CLF:2026-10-19",
"ema_trend": "12.88 > 12.48 > 12.1",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:17:00.453928Z",
"facts": [
"The sealed news item describes the quarter as the strongest in three years and also notes a revenue miss.",
"The supplied quote snapshot records a $13.945 price and a +15.06% change against the $12.12 previous regular close; volume was 1.77 times its three-month average.",
"The later provider series ended at a +16.254128% return. The supplied 20-session comparison reports +16.94% for CLF, +2.35% for XLB and +14.59 percentage points of excess return versus XLB.",
"A same-day SEC 8-K record is present, but its contents are not summarized in the sealed packet."
],
"benchmark_excess_pct": {
"sp500": -3.474,
"nasdaq100": -3.0577,
"russell2000": -4.8438
},
"price_as_of": "2026-10-20T23:08:59Z",
"vwap_as_of": null
},
{
"symbol": "MRKR",
"role": "alternative",
"price": 1.16,
"base_price": 1.1,
"return_since_base_pct": 5.4545,
"session_return_pct": -3.3333,
"change_since_prior_pct": 0.0,
"volume_ratio": 4.6,
"rsi": 50.0,
"vwap": 1.11,
"vwap_distance_pct": 4.5045,
"position_52w_pct": 44.72,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:29:36Z",
"source": "yfinance_quote",
"name": "Marker Therapeutics, Inc.",
"episode_id": "n0:MRKR:2026-10-19",
"ema_trend": "1.01 > 1.05 > 1.12",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:15:55.926875Z",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"benchmark_excess_pct": {
"sp500": -3.6173,
"nasdaq100": -3.201,
"russell2000": -4.9871
},
"price_as_of": "2026-10-19T20:29:36Z",
"vwap_as_of": null
},
{
"symbol": "ATNM",
"role": "alternative",
"price": 1.32,
"base_price": 1.3501,
"return_since_base_pct": -2.2295,
"session_return_pct": 19.48,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.99,
"rsi": 63.82,
"vwap": 1.29,
"vwap_distance_pct": 2.3256,
"position_52w_pct": 77.59,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:56:04Z",
"source": "yfinance_quote",
"name": "Actinium Pharmaceuticals, Inc.",
"episode_id": "n0:ATNM:2026-10-19",
"ema_trend": "1.13 > 1.13 > 1.09",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:16:17.856663Z",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"benchmark_excess_pct": {
"sp500": 19.196,
"nasdaq100": 19.6123,
"russell2000": 17.8262
},
"price_as_of": "2026-10-19T20:56:04Z",
"vwap_as_of": null
},
{
"symbol": "INFY",
"role": "alternative",
"price": 12.2407,
"base_price": 12.275,
"return_since_base_pct": -0.2794,
"session_return_pct": 0.3336,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": 75.27,
"vwap": 12.15,
"vwap_distance_pct": 0.7465,
"position_52w_pct": 40.92,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:55:19Z",
"source": "yfinance_quote",
"name": "Infosys Limited",
"episode_id": "narrative:INFY:40115d2cb35fa2f1",
"ema_trend": "11.6 > 11.3 > 11.37",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:40Z",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"benchmark_excess_pct": {
"sp500": 0.0496,
"nasdaq100": 0.4659,
"russell2000": -1.3202
},
"price_as_of": "2026-10-19T20:55:19Z",
"vwap_as_of": null
},
{
"symbol": "G",
"role": "alternative",
"price": 37.68,
"base_price": 37.68,
"return_since_base_pct": 0.0,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.15,
"rsi": 78.15,
"vwap": 37.36,
"vwap_distance_pct": 0.8565,
"position_52w_pct": 77.57,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:00:47Z",
"source": "yfinance_quote",
"name": "Genpact Limited",
"episode_id": "narrative:G:62d41fe65f9523e4",
"ema_trend": "35.96 > 35.14 > 34.75",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:30Z",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"price_as_of": "2026-10-19T21:00:47Z",
"vwap_as_of": null
},
{
"symbol": "RIGL",
"role": "alternative",
"price": 46.72,
"base_price": 47.1998,
"return_since_base_pct": -1.0165,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.19,
"rsi": 43.29,
"vwap": 46.66,
"vwap_distance_pct": 0.1286,
"position_52w_pct": 90.35,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:01Z",
"source": "yfinance_quote",
"name": "Rigel Pharmaceuticals, Inc.",
"episode_id": "narrative:RIGL:ca95148af41e4931",
"ema_trend": "47.29 > 47.31 > 45.84",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:45Z",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"price_as_of": "2026-10-19T20:00:01Z",
"vwap_as_of": null
},
{
"symbol": "WDAY",
"role": "alternative",
"price": 195.2,
"base_price": 193.84,
"return_since_base_pct": 0.7016,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.18,
"rsi": 55.62,
"vwap": 192.67,
"vwap_distance_pct": 1.3131,
"position_52w_pct": 78.33,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:06:04Z",
"source": "yfinance_quote",
"name": "Workday, Inc.",
"episode_id": "narrative:WDAY:15757f112d8d2f99",
"ema_trend": "190.5 > 189.74 > 185.71",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:42Z",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"price_as_of": "2026-10-19T21:06:04Z",
"vwap_as_of": null
},
{
"symbol": "ESLT",
"role": "alternative",
"price": 759.47,
"base_price": 759.42,
"return_since_base_pct": 0.0066,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.57,
"rsi": 63.56,
"vwap": 754.86,
"vwap_distance_pct": 0.6107,
"position_52w_pct": 74.74,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:12Z",
"source": "yfinance_quote",
"name": "Elbit Systems Ltd.",
"episode_id": "narrative:ESLT:ae731078c5dd8bf2",
"ema_trend": "716.16 > 710.5 > 728.89",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:44Z",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"price_as_of": "2026-10-19T20:00:12Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7712.57,
"base_price": 7690.73,
"return_since_base_pct": 0.284,
"session_return_pct": 0.284,
"as_of": "2026-10-21T00:05:54.964695Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29490.283,
"base_price": 29529.344,
"return_since_base_pct": -0.1323,
"session_return_pct": -0.1323,
"as_of": "2026-10-21T00:05:54.964695Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2773.4197,
"base_price": 2728.298,
"return_since_base_pct": 1.6538,
"session_return_pct": 1.6538,
"as_of": "2026-10-21T00:05:54.964695Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 8,
"candidate_prices": 8,
"candidate_technical": 8,
"benchmark_rows": 3
}
}
},
{
"day": 2,
"timestamp": "2026-10-21T21:52:37.216082Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-21T21:52:37.216082Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CLF",
"role": "selected",
"price": 14.06,
"base_price": 13.93,
"return_since_base_pct": 0.9332,
"session_return_pct": 2.78,
"change_since_prior_pct": 2.853,
"volume_ratio": 1.14,
"rsi": 71.84,
"vwap": 13.92,
"vwap_distance_pct": 1.0057,
"position_52w_pct": 91.4,
"extended_hours_pct": 0.2,
"as_of": "2026-10-21T20:37:07Z",
"source": "sealed_extended_quote",
"name": "Cleveland-Cliffs Inc.",
"episode_id": "n0:CLF:2026-10-19",
"ema_trend": "13.11 > 12.62 > 12.17",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:17:00.453928Z",
"facts": [
"The sealed news item describes the quarter as the strongest in three years and also notes a revenue miss.",
"The supplied quote snapshot records a $13.945 price and a +15.06% change against the $12.12 previous regular close; volume was 1.77 times its three-month average.",
"The later provider series ended at a +16.254128% return. The supplied 20-session comparison reports +16.94% for CLF, +2.35% for XLB and +14.59 percentage points of excess return versus XLB.",
"A same-day SEC 8-K record is present, but its contents are not summarized in the sealed packet."
],
"benchmark_excess_pct": {
"sp500": 2.2279,
"nasdaq100": 1.5139,
"russell2000": 2.431
},
"price_as_of": "2026-10-21T20:37:07Z",
"vwap_as_of": null
},
{
"symbol": "MRKR",
"role": "alternative",
"price": 1.16,
"base_price": 1.1,
"return_since_base_pct": 5.4545,
"session_return_pct": -3.3333,
"change_since_prior_pct": 0.0,
"volume_ratio": 4.6,
"rsi": 50.0,
"vwap": 1.11,
"vwap_distance_pct": 4.5045,
"position_52w_pct": 44.72,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:29:36Z",
"source": "yfinance_quote",
"name": "Marker Therapeutics, Inc.",
"episode_id": "n0:MRKR:2026-10-19",
"ema_trend": "1.01 > 1.05 > 1.12",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:15:55.926875Z",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"benchmark_excess_pct": {
"sp500": -3.8854,
"nasdaq100": -4.5994,
"russell2000": -3.6823
},
"price_as_of": "2026-10-19T20:29:36Z",
"vwap_as_of": null
},
{
"symbol": "ATNM",
"role": "alternative",
"price": 1.32,
"base_price": 1.3501,
"return_since_base_pct": -2.2295,
"session_return_pct": 19.48,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.99,
"rsi": 63.82,
"vwap": 1.29,
"vwap_distance_pct": 2.3256,
"position_52w_pct": 77.59,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:56:04Z",
"source": "yfinance_quote",
"name": "Actinium Pharmaceuticals, Inc.",
"episode_id": "n0:ATNM:2026-10-19",
"ema_trend": "1.13 > 1.13 > 1.09",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:16:17.856663Z",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"benchmark_excess_pct": {
"sp500": 18.9279,
"nasdaq100": 18.2139,
"russell2000": 19.131
},
"price_as_of": "2026-10-19T20:56:04Z",
"vwap_as_of": null
},
{
"symbol": "INFY",
"role": "alternative",
"price": 12.2407,
"base_price": 12.275,
"return_since_base_pct": -0.2794,
"session_return_pct": 0.3336,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": 75.27,
"vwap": 12.15,
"vwap_distance_pct": 0.7465,
"position_52w_pct": 40.92,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:55:19Z",
"source": "yfinance_quote",
"name": "Infosys Limited",
"episode_id": "narrative:INFY:40115d2cb35fa2f1",
"ema_trend": "11.6 > 11.3 > 11.37",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:40Z",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"benchmark_excess_pct": {
"sp500": -0.2185,
"nasdaq100": -0.9325,
"russell2000": -0.0154
},
"price_as_of": "2026-10-19T20:55:19Z",
"vwap_as_of": null
},
{
"symbol": "G",
"role": "alternative",
"price": 37.68,
"base_price": 37.68,
"return_since_base_pct": 0.0,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.15,
"rsi": 78.15,
"vwap": 37.36,
"vwap_distance_pct": 0.8565,
"position_52w_pct": 77.57,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:00:47Z",
"source": "yfinance_quote",
"name": "Genpact Limited",
"episode_id": "narrative:G:62d41fe65f9523e4",
"ema_trend": "35.96 > 35.14 > 34.75",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:30Z",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"price_as_of": "2026-10-19T21:00:47Z",
"vwap_as_of": null
},
{
"symbol": "RIGL",
"role": "alternative",
"price": 46.72,
"base_price": 47.1998,
"return_since_base_pct": -1.0165,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.19,
"rsi": 43.29,
"vwap": 46.66,
"vwap_distance_pct": 0.1286,
"position_52w_pct": 90.35,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:01Z",
"source": "yfinance_quote",
"name": "Rigel Pharmaceuticals, Inc.",
"episode_id": "narrative:RIGL:ca95148af41e4931",
"ema_trend": "47.29 > 47.31 > 45.84",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:45Z",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"price_as_of": "2026-10-19T20:00:01Z",
"vwap_as_of": null
},
{
"symbol": "WDAY",
"role": "alternative",
"price": 195.2,
"base_price": 193.84,
"return_since_base_pct": 0.7016,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.18,
"rsi": 55.62,
"vwap": 192.67,
"vwap_distance_pct": 1.3131,
"position_52w_pct": 78.33,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:06:04Z",
"source": "yfinance_quote",
"name": "Workday, Inc.",
"episode_id": "narrative:WDAY:15757f112d8d2f99",
"ema_trend": "190.5 > 189.74 > 185.71",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:42Z",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"price_as_of": "2026-10-19T21:06:04Z",
"vwap_as_of": null
},
{
"symbol": "ESLT",
"role": "alternative",
"price": 759.47,
"base_price": 759.42,
"return_since_base_pct": 0.0066,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.57,
"rsi": 63.56,
"vwap": 754.86,
"vwap_distance_pct": 0.6107,
"position_52w_pct": 74.74,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:12Z",
"source": "yfinance_quote",
"name": "Elbit Systems Ltd.",
"episode_id": "narrative:ESLT:ae731078c5dd8bf2",
"ema_trend": "716.16 > 710.5 > 728.89",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:44Z",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"price_as_of": "2026-10-19T20:00:12Z",
"vwap_as_of": null
}
],
"benchmarks": [
{
"id": "sp500",
"symbol": "^GSPC",
"label": "S&P 500",
"role": "benchmark",
"price": 7755.15,
"base_price": 7712.57,
"return_since_base_pct": 0.5521,
"session_return_pct": 0.5521,
"as_of": "2026-10-21T16:43:22.625302Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "nasdaq100",
"symbol": "^NDX",
"label": "Nasdaq 100",
"role": "benchmark",
"price": 29863.658,
"base_price": 29490.283,
"return_since_base_pct": 1.2661,
"session_return_pct": 1.2661,
"as_of": "2026-10-21T16:43:22.625302Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
},
{
"id": "russell2000",
"symbol": "^RUT",
"label": "Russell 2000",
"role": "benchmark",
"price": 2783.0996,
"base_price": 2773.4197,
"return_since_base_pct": 0.349,
"session_return_pct": 0.349,
"as_of": "2026-10-21T16:43:22.625302Z",
"source": "yfinance.ticker_info",
"base_definition": "previous regular close"
}
],
"coverage": {
"candidate_rows": 8,
"candidate_prices": 8,
"candidate_technical": 8,
"benchmark_rows": 3
}
}
},
{
"day": 3,
"timestamp": "2026-10-22T19:46:04.050191Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-22T19:46:04.050191Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"rows": [
{
"symbol": "CLF",
"role": "selected",
"price": 13.245,
"base_price": 13.93,
"return_since_base_pct": -4.9174,
"session_return_pct": -5.6,
"change_since_prior_pct": -5.7966,
"volume_ratio": 1.28,
"rsi": 64.82,
"vwap": 13.47,
"vwap_distance_pct": -1.6704,
"position_52w_pct": 86.3,
"extended_hours_pct": null,
"as_of": "2026-10-22T19:21:50.306215Z",
"source": "yfinance_quote",
"name": "Cleveland-Cliffs Inc.",
"episode_id": "n0:CLF:2026-10-19",
"ema_trend": "13.14 > 12.68 > 12.22",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:17:00.453928Z",
"facts": [
"The sealed news item describes the quarter as the strongest in three years and also notes a revenue miss.",
"The supplied quote snapshot records a $13.945 price and a +15.06% change against the $12.12 previous regular close; volume was 1.77 times its three-month average.",
"The later provider series ended at a +16.254128% return. The supplied 20-session comparison reports +16.94% for CLF, +2.35% for XLB and +14.59 percentage points of excess return versus XLB.",
"A same-day SEC 8-K record is present, but its contents are not summarized in the sealed packet."
],
"price_as_of": "2026-10-22T19:21:50.306215Z",
"vwap_as_of": null
},
{
"symbol": "MRKR",
"role": "alternative",
"price": 1.16,
"base_price": 1.1,
"return_since_base_pct": 5.4545,
"session_return_pct": -3.3333,
"change_since_prior_pct": 0.0,
"volume_ratio": 4.6,
"rsi": 50.0,
"vwap": 1.11,
"vwap_distance_pct": 4.5045,
"position_52w_pct": 44.72,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:29:36Z",
"source": "yfinance_quote",
"name": "Marker Therapeutics, Inc.",
"episode_id": "n0:MRKR:2026-10-19",
"ema_trend": "1.01 > 1.05 > 1.12",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:15:55.926875Z",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"price_as_of": "2026-10-19T20:29:36Z",
"vwap_as_of": null
},
{
"symbol": "ATNM",
"role": "alternative",
"price": 1.32,
"base_price": 1.3501,
"return_since_base_pct": -2.2295,
"session_return_pct": 19.48,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.99,
"rsi": 63.82,
"vwap": 1.29,
"vwap_distance_pct": 2.3256,
"position_52w_pct": 77.59,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:56:04Z",
"source": "yfinance_quote",
"name": "Actinium Pharmaceuticals, Inc.",
"episode_id": "n0:ATNM:2026-10-19",
"ema_trend": "1.13 > 1.13 > 1.09",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:16:17.856663Z",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"price_as_of": "2026-10-19T20:56:04Z",
"vwap_as_of": null
},
{
"symbol": "INFY",
"role": "alternative",
"price": 12.2407,
"base_price": 12.275,
"return_since_base_pct": -0.2794,
"session_return_pct": 0.3336,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": 75.27,
"vwap": 12.15,
"vwap_distance_pct": 0.7465,
"position_52w_pct": 40.92,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:55:19Z",
"source": "yfinance_quote",
"name": "Infosys Limited",
"episode_id": "narrative:INFY:40115d2cb35fa2f1",
"ema_trend": "11.6 > 11.3 > 11.37",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:40Z",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"price_as_of": "2026-10-19T20:55:19Z",
"vwap_as_of": null
},
{
"symbol": "G",
"role": "alternative",
"price": 37.68,
"base_price": 37.68,
"return_since_base_pct": 0.0,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.15,
"rsi": 78.15,
"vwap": 37.36,
"vwap_distance_pct": 0.8565,
"position_52w_pct": 77.57,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:00:47Z",
"source": "yfinance_quote",
"name": "Genpact Limited",
"episode_id": "narrative:G:62d41fe65f9523e4",
"ema_trend": "35.96 > 35.14 > 34.75",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:30Z",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"price_as_of": "2026-10-19T21:00:47Z",
"vwap_as_of": null
},
{
"symbol": "RIGL",
"role": "alternative",
"price": 46.72,
"base_price": 47.1998,
"return_since_base_pct": -1.0165,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.19,
"rsi": 43.29,
"vwap": 46.66,
"vwap_distance_pct": 0.1286,
"position_52w_pct": 90.35,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:01Z",
"source": "yfinance_quote",
"name": "Rigel Pharmaceuticals, Inc.",
"episode_id": "narrative:RIGL:ca95148af41e4931",
"ema_trend": "47.29 > 47.31 > 45.84",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:45Z",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"price_as_of": "2026-10-19T20:00:01Z",
"vwap_as_of": null
},
{
"symbol": "WDAY",
"role": "alternative",
"price": 195.2,
"base_price": 193.84,
"return_since_base_pct": 0.7016,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.18,
"rsi": 55.62,
"vwap": 192.67,
"vwap_distance_pct": 1.3131,
"position_52w_pct": 78.33,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:06:04Z",
"source": "yfinance_quote",
"name": "Workday, Inc.",
"episode_id": "narrative:WDAY:15757f112d8d2f99",
"ema_trend": "190.5 > 189.74 > 185.71",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:42Z",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"price_as_of": "2026-10-19T21:06:04Z",
"vwap_as_of": null
},
{
"symbol": "ESLT",
"role": "alternative",
"price": 759.47,
"base_price": 759.42,
"return_since_base_pct": 0.0066,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.57,
"rsi": 63.56,
"vwap": 754.86,
"vwap_distance_pct": 0.6107,
"position_52w_pct": 74.74,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:12Z",
"source": "yfinance_quote",
"name": "Elbit Systems Ltd.",
"episode_id": "narrative:ESLT:ae731078c5dd8bf2",
"ema_trend": "716.16 > 710.5 > 728.89",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:44Z",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"price_as_of": "2026-10-19T20:00:12Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 8,
"candidate_prices": 8,
"candidate_technical": 8,
"benchmark_rows": 0
}
}
},
{
"day": 3,
"timestamp": "2026-10-22T22:04:48.411836Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-22T22:04:48.411836Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"decision_reference": {
"decision_id": "n0:CLF:2026-10-19:initial",
"decision_at": "2026-10-19T18:14:42.286505Z"
},
"rows": [
{
"symbol": "CLF",
"role": "selected",
"price": 13.1,
"base_price": 13.93,
"return_since_base_pct": -5.9584,
"session_return_pct": -6.99,
"change_since_prior_pct": -1.0948,
"volume_ratio": 1.73,
"rsi": 62.93,
"vwap": 13.47,
"vwap_distance_pct": -2.7468,
"position_52w_pct": 85.0,
"extended_hours_pct": 0.35,
"as_of": "2026-10-22T21:20:41Z",
"source": "sealed_extended_quote",
"name": "Cleveland-Cliffs Inc.",
"episode_id": "n0:CLF:2026-10-19",
"ema_trend": "13.1 > 12.66 > 12.21",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:17:00.453928Z",
"facts": [
"The sealed news item describes the quarter as the strongest in three years and also notes a revenue miss.",
"The supplied quote snapshot records a $13.945 price and a +15.06% change against the $12.12 previous regular close; volume was 1.77 times its three-month average.",
"The later provider series ended at a +16.254128% return. The supplied 20-session comparison reports +16.94% for CLF, +2.35% for XLB and +14.59 percentage points of excess return versus XLB.",
"A same-day SEC 8-K record is present, but its contents are not summarized in the sealed packet."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:17:00.453928+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-22T21:20:41Z",
"vwap_as_of": null
},
{
"symbol": "MRKR",
"role": "alternative",
"price": 1.16,
"base_price": 1.1,
"return_since_base_pct": 5.4545,
"session_return_pct": -3.3333,
"change_since_prior_pct": 0.0,
"volume_ratio": 4.6,
"rsi": 50.0,
"vwap": 1.11,
"vwap_distance_pct": 4.5045,
"position_52w_pct": 44.72,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:29:36Z",
"source": "yfinance_quote",
"name": "Marker Therapeutics, Inc.",
"episode_id": "n0:MRKR:2026-10-19",
"ema_trend": "1.01 > 1.05 > 1.12",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:15:55.926875Z",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:15:55.926875+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:29:36Z",
"vwap_as_of": null
},
{
"symbol": "ATNM",
"role": "alternative",
"price": 1.32,
"base_price": 1.3501,
"return_since_base_pct": -2.2295,
"session_return_pct": 19.48,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.99,
"rsi": 63.82,
"vwap": 1.29,
"vwap_distance_pct": 2.3256,
"position_52w_pct": 77.59,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:56:04Z",
"source": "yfinance_quote",
"name": "Actinium Pharmaceuticals, Inc.",
"episode_id": "n0:ATNM:2026-10-19",
"ema_trend": "1.13 > 1.13 > 1.09",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:16:17.856663Z",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:16:17.856663+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:56:04Z",
"vwap_as_of": null
},
{
"symbol": "INFY",
"role": "alternative",
"price": 12.2407,
"base_price": 12.275,
"return_since_base_pct": -0.2794,
"session_return_pct": 0.3336,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": 75.27,
"vwap": 12.15,
"vwap_distance_pct": 0.7465,
"position_52w_pct": 40.92,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:55:19Z",
"source": "yfinance_quote",
"name": "Infosys Limited",
"episode_id": "narrative:INFY:40115d2cb35fa2f1",
"ema_trend": "11.6 > 11.3 > 11.37",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:40Z",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:40+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:55:19Z",
"vwap_as_of": null
},
{
"symbol": "G",
"role": "alternative",
"price": 37.68,
"base_price": 37.68,
"return_since_base_pct": 0.0,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.15,
"rsi": 78.15,
"vwap": 37.36,
"vwap_distance_pct": 0.8565,
"position_52w_pct": 77.57,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:00:47Z",
"source": "yfinance_quote",
"name": "Genpact Limited",
"episode_id": "narrative:G:62d41fe65f9523e4",
"ema_trend": "35.96 > 35.14 > 34.75",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:30Z",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:30+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T21:00:47Z",
"vwap_as_of": null
},
{
"symbol": "RIGL",
"role": "alternative",
"price": 46.72,
"base_price": 47.1998,
"return_since_base_pct": -1.0165,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.19,
"rsi": 43.29,
"vwap": 46.66,
"vwap_distance_pct": 0.1286,
"position_52w_pct": 90.35,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:01Z",
"source": "yfinance_quote",
"name": "Rigel Pharmaceuticals, Inc.",
"episode_id": "narrative:RIGL:ca95148af41e4931",
"ema_trend": "47.29 > 47.31 > 45.84",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:45Z",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:18:45+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:00:01Z",
"vwap_as_of": null
},
{
"symbol": "WDAY",
"role": "alternative",
"price": 195.2,
"base_price": 193.84,
"return_since_base_pct": 0.7016,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.18,
"rsi": 55.62,
"vwap": 192.67,
"vwap_distance_pct": 1.3131,
"position_52w_pct": 78.33,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:06:04Z",
"source": "yfinance_quote",
"name": "Workday, Inc.",
"episode_id": "narrative:WDAY:15757f112d8d2f99",
"ema_trend": "190.5 > 189.74 > 185.71",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:42Z",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:42+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T21:06:04Z",
"vwap_as_of": null
},
{
"symbol": "ESLT",
"role": "alternative",
"price": 759.47,
"base_price": 759.42,
"return_since_base_pct": 0.0066,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.57,
"rsi": 63.56,
"vwap": 754.86,
"vwap_distance_pct": 0.6107,
"position_52w_pct": 74.74,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:12Z",
"source": "yfinance_quote",
"name": "Elbit Systems Ltd.",
"episode_id": "narrative:ESLT:ae731078c5dd8bf2",
"ema_trend": "716.16 > 710.5 > 728.89",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:44Z",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:18:44+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:00:12Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 8,
"candidate_prices": 8,
"candidate_technical": 8,
"benchmark_rows": 0,
"day0_close_rows": 8,
"day0_close_prices": 0,
"day0_close_benchmark_rows": 0
}
}
},
{
"day": 4,
"timestamp": "2026-10-23T14:58:24.560289Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-23T14:58:24.560289Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"decision_reference": {
"decision_id": "n0:CLF:2026-10-19:initial",
"decision_at": "2026-10-19T18:14:42.286505Z"
},
"rows": [
{
"symbol": "CLF",
"role": "selected",
"price": 13.41,
"base_price": 13.93,
"return_since_base_pct": -3.733,
"session_return_pct": 2.76,
"change_since_prior_pct": 2.3664,
"volume_ratio": 0.12,
"rsi": 59.84,
"vwap": 13.35,
"vwap_distance_pct": 0.4494,
"position_52w_pct": 87.4,
"extended_hours_pct": null,
"as_of": "2026-10-23T14:06:04.621810Z",
"source": "yfinance_quote",
"name": "Cleveland-Cliffs Inc.",
"episode_id": "n0:CLF:2026-10-19",
"ema_trend": "13.16 > 12.73 > 12.25",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:17:00.453928Z",
"facts": [
"The sealed news item describes the quarter as the strongest in three years and also notes a revenue miss.",
"The supplied quote snapshot records a $13.945 price and a +15.06% change against the $12.12 previous regular close; volume was 1.77 times its three-month average.",
"The later provider series ended at a +16.254128% return. The supplied 20-session comparison reports +16.94% for CLF, +2.35% for XLB and +14.59 percentage points of excess return versus XLB.",
"A same-day SEC 8-K record is present, but its contents are not summarized in the sealed packet."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:17:00.453928+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-23T14:06:04.621810Z",
"vwap_as_of": null
},
{
"symbol": "MRKR",
"role": "alternative",
"price": 1.16,
"base_price": 1.1,
"return_since_base_pct": 5.4545,
"session_return_pct": -3.3333,
"change_since_prior_pct": 0.0,
"volume_ratio": 4.6,
"rsi": 50.0,
"vwap": 1.11,
"vwap_distance_pct": 4.5045,
"position_52w_pct": 44.72,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:29:36Z",
"source": "yfinance_quote",
"name": "Marker Therapeutics, Inc.",
"episode_id": "n0:MRKR:2026-10-19",
"ema_trend": "1.01 > 1.05 > 1.12",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:15:55.926875Z",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:15:55.926875+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:29:36Z",
"vwap_as_of": null
},
{
"symbol": "ATNM",
"role": "alternative",
"price": 1.32,
"base_price": 1.3501,
"return_since_base_pct": -2.2295,
"session_return_pct": 19.48,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.99,
"rsi": 63.82,
"vwap": 1.29,
"vwap_distance_pct": 2.3256,
"position_52w_pct": 77.59,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:56:04Z",
"source": "yfinance_quote",
"name": "Actinium Pharmaceuticals, Inc.",
"episode_id": "n0:ATNM:2026-10-19",
"ema_trend": "1.13 > 1.13 > 1.09",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:16:17.856663Z",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:16:17.856663+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:56:04Z",
"vwap_as_of": null
},
{
"symbol": "INFY",
"role": "alternative",
"price": 12.2407,
"base_price": 12.275,
"return_since_base_pct": -0.2794,
"session_return_pct": 0.3336,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": 75.27,
"vwap": 12.15,
"vwap_distance_pct": 0.7465,
"position_52w_pct": 40.92,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:55:19Z",
"source": "yfinance_quote",
"name": "Infosys Limited",
"episode_id": "narrative:INFY:40115d2cb35fa2f1",
"ema_trend": "11.6 > 11.3 > 11.37",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:40Z",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:40+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:55:19Z",
"vwap_as_of": null
},
{
"symbol": "G",
"role": "alternative",
"price": 37.68,
"base_price": 37.68,
"return_since_base_pct": 0.0,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.15,
"rsi": 78.15,
"vwap": 37.36,
"vwap_distance_pct": 0.8565,
"position_52w_pct": 77.57,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:00:47Z",
"source": "yfinance_quote",
"name": "Genpact Limited",
"episode_id": "narrative:G:62d41fe65f9523e4",
"ema_trend": "35.96 > 35.14 > 34.75",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:30Z",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:30+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T21:00:47Z",
"vwap_as_of": null
},
{
"symbol": "RIGL",
"role": "alternative",
"price": 46.72,
"base_price": 47.1998,
"return_since_base_pct": -1.0165,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.19,
"rsi": 43.29,
"vwap": 46.66,
"vwap_distance_pct": 0.1286,
"position_52w_pct": 90.35,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:01Z",
"source": "yfinance_quote",
"name": "Rigel Pharmaceuticals, Inc.",
"episode_id": "narrative:RIGL:ca95148af41e4931",
"ema_trend": "47.29 > 47.31 > 45.84",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:45Z",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:18:45+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:00:01Z",
"vwap_as_of": null
},
{
"symbol": "WDAY",
"role": "alternative",
"price": 195.2,
"base_price": 193.84,
"return_since_base_pct": 0.7016,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.18,
"rsi": 55.62,
"vwap": 192.67,
"vwap_distance_pct": 1.3131,
"position_52w_pct": 78.33,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:06:04Z",
"source": "yfinance_quote",
"name": "Workday, Inc.",
"episode_id": "narrative:WDAY:15757f112d8d2f99",
"ema_trend": "190.5 > 189.74 > 185.71",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:42Z",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:42+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T21:06:04Z",
"vwap_as_of": null
},
{
"symbol": "ESLT",
"role": "alternative",
"price": 759.47,
"base_price": 759.42,
"return_since_base_pct": 0.0066,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.57,
"rsi": 63.56,
"vwap": 754.86,
"vwap_distance_pct": 0.6107,
"position_52w_pct": 74.74,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:12Z",
"source": "yfinance_quote",
"name": "Elbit Systems Ltd.",
"episode_id": "narrative:ESLT:ae731078c5dd8bf2",
"ema_trend": "716.16 > 710.5 > 728.89",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:44Z",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:18:44+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:00:12Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 8,
"candidate_prices": 8,
"candidate_technical": 8,
"benchmark_rows": 0,
"day0_close_rows": 8,
"day0_close_prices": 0,
"day0_close_benchmark_rows": 0
}
}
},
{
"day": 4,
"timestamp": "2026-10-23T19:56:02.629117Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-23T19:56:02.629117Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"decision_reference": {
"decision_id": "n0:CLF:2026-10-19:initial",
"decision_at": "2026-10-19T18:14:42.286505Z"
},
"rows": [
{
"symbol": "CLF",
"role": "selected",
"price": 14.0,
"base_price": 13.93,
"return_since_base_pct": 0.5025,
"session_return_pct": 7.28,
"change_since_prior_pct": 4.3997,
"volume_ratio": 1.04,
"rsi": 63.31,
"vwap": 13.82,
"vwap_distance_pct": 1.3025,
"position_52w_pct": 91.2,
"extended_hours_pct": null,
"as_of": "2026-10-23T19:22:12.987963Z",
"source": "yfinance_quote",
"name": "Cleveland-Cliffs Inc.",
"episode_id": "n0:CLF:2026-10-19",
"ema_trend": "13.28 > 12.78 > 12.28",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:17:00.453928Z",
"facts": [
"The sealed news item describes the quarter as the strongest in three years and also notes a revenue miss.",
"The supplied quote snapshot records a $13.945 price and a +15.06% change against the $12.12 previous regular close; volume was 1.77 times its three-month average.",
"The later provider series ended at a +16.254128% return. The supplied 20-session comparison reports +16.94% for CLF, +2.35% for XLB and +14.59 percentage points of excess return versus XLB.",
"A same-day SEC 8-K record is present, but its contents are not summarized in the sealed packet."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:17:00.453928+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-23T19:22:12.987963Z",
"vwap_as_of": null
},
{
"symbol": "MRKR",
"role": "alternative",
"price": 1.16,
"base_price": 1.1,
"return_since_base_pct": 5.4545,
"session_return_pct": -3.3333,
"change_since_prior_pct": 0.0,
"volume_ratio": 4.6,
"rsi": 50.0,
"vwap": 1.11,
"vwap_distance_pct": 4.5045,
"position_52w_pct": 44.72,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:29:36Z",
"source": "yfinance_quote",
"name": "Marker Therapeutics, Inc.",
"episode_id": "n0:MRKR:2026-10-19",
"ema_trend": "1.01 > 1.05 > 1.12",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:15:55.926875Z",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:15:55.926875+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:29:36Z",
"vwap_as_of": null
},
{
"symbol": "ATNM",
"role": "alternative",
"price": 1.32,
"base_price": 1.3501,
"return_since_base_pct": -2.2295,
"session_return_pct": 19.48,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.99,
"rsi": 63.82,
"vwap": 1.29,
"vwap_distance_pct": 2.3256,
"position_52w_pct": 77.59,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:56:04Z",
"source": "yfinance_quote",
"name": "Actinium Pharmaceuticals, Inc.",
"episode_id": "n0:ATNM:2026-10-19",
"ema_trend": "1.13 > 1.13 > 1.09",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:16:17.856663Z",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:16:17.856663+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:56:04Z",
"vwap_as_of": null
},
{
"symbol": "INFY",
"role": "alternative",
"price": 12.2407,
"base_price": 12.275,
"return_since_base_pct": -0.2794,
"session_return_pct": 0.3336,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": 75.27,
"vwap": 12.15,
"vwap_distance_pct": 0.7465,
"position_52w_pct": 40.92,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:55:19Z",
"source": "yfinance_quote",
"name": "Infosys Limited",
"episode_id": "narrative:INFY:40115d2cb35fa2f1",
"ema_trend": "11.6 > 11.3 > 11.37",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:40Z",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:40+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:55:19Z",
"vwap_as_of": null
},
{
"symbol": "G",
"role": "alternative",
"price": 37.68,
"base_price": 37.68,
"return_since_base_pct": 0.0,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.15,
"rsi": 78.15,
"vwap": 37.36,
"vwap_distance_pct": 0.8565,
"position_52w_pct": 77.57,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:00:47Z",
"source": "yfinance_quote",
"name": "Genpact Limited",
"episode_id": "narrative:G:62d41fe65f9523e4",
"ema_trend": "35.96 > 35.14 > 34.75",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:30Z",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:30+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T21:00:47Z",
"vwap_as_of": null
},
{
"symbol": "RIGL",
"role": "alternative",
"price": 46.72,
"base_price": 47.1998,
"return_since_base_pct": -1.0165,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.19,
"rsi": 43.29,
"vwap": 46.66,
"vwap_distance_pct": 0.1286,
"position_52w_pct": 90.35,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:01Z",
"source": "yfinance_quote",
"name": "Rigel Pharmaceuticals, Inc.",
"episode_id": "narrative:RIGL:ca95148af41e4931",
"ema_trend": "47.29 > 47.31 > 45.84",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:45Z",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:18:45+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:00:01Z",
"vwap_as_of": null
},
{
"symbol": "WDAY",
"role": "alternative",
"price": 195.2,
"base_price": 193.84,
"return_since_base_pct": 0.7016,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.18,
"rsi": 55.62,
"vwap": 192.67,
"vwap_distance_pct": 1.3131,
"position_52w_pct": 78.33,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:06:04Z",
"source": "yfinance_quote",
"name": "Workday, Inc.",
"episode_id": "narrative:WDAY:15757f112d8d2f99",
"ema_trend": "190.5 > 189.74 > 185.71",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:42Z",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:42+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T21:06:04Z",
"vwap_as_of": null
},
{
"symbol": "ESLT",
"role": "alternative",
"price": 759.47,
"base_price": 759.42,
"return_since_base_pct": 0.0066,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.57,
"rsi": 63.56,
"vwap": 754.86,
"vwap_distance_pct": 0.6107,
"position_52w_pct": 74.74,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:12Z",
"source": "yfinance_quote",
"name": "Elbit Systems Ltd.",
"episode_id": "narrative:ESLT:ae731078c5dd8bf2",
"ema_trend": "716.16 > 710.5 > 728.89",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:44Z",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:18:44+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:00:12Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 8,
"candidate_prices": 8,
"candidate_technical": 8,
"benchmark_rows": 0,
"day0_close_rows": 8,
"day0_close_prices": 0,
"day0_close_benchmark_rows": 0
}
}
},
{
"day": 4,
"timestamp": "2026-10-23T22:04:24.201733Z",
"comparison": {
"schema_version": "public-candidate-comparison.v1",
"captured_at": "2026-10-23T22:04:24.201733Z",
"base_definition": "Candidates use the publication reference; benchmarks use the previous regular close.",
"source": "sealed_update_market_context + canonical_candidate_snapshot + market_trajectory + public_market_snapshot",
"decision_reference": {
"decision_id": "n0:CLF:2026-10-19:initial",
"decision_at": "2026-10-19T18:14:42.286505Z"
},
"rows": [
{
"symbol": "CLF",
"role": "selected",
"price": 13.92,
"base_price": 13.93,
"return_since_base_pct": -0.0718,
"session_return_pct": 6.51,
"change_since_prior_pct": -0.5714,
"volume_ratio": 1.41,
"rsi": 62.76,
"vwap": 13.82,
"vwap_distance_pct": 0.7236,
"position_52w_pct": 90.6,
"extended_hours_pct": 0.15,
"as_of": "2026-10-23T21:24:41Z",
"source": "sealed_extended_quote",
"name": "Cleveland-Cliffs Inc.",
"episode_id": "n0:CLF:2026-10-19",
"ema_trend": "13.26 > 12.77 > 12.27",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:17:00.453928Z",
"facts": [
"The sealed news item describes the quarter as the strongest in three years and also notes a revenue miss.",
"The supplied quote snapshot records a $13.945 price and a +15.06% change against the $12.12 previous regular close; volume was 1.77 times its three-month average.",
"The later provider series ended at a +16.254128% return. The supplied 20-session comparison reports +16.94% for CLF, +2.35% for XLB and +14.59 percentage points of excess return versus XLB.",
"A same-day SEC 8-K record is present, but its contents are not summarized in the sealed packet."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:17:00.453928+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-23T21:24:41Z",
"vwap_as_of": null
},
{
"symbol": "MRKR",
"role": "alternative",
"price": 1.16,
"base_price": 1.1,
"return_since_base_pct": 5.4545,
"session_return_pct": -3.3333,
"change_since_prior_pct": 0.0,
"volume_ratio": 4.6,
"rsi": 50.0,
"vwap": 1.11,
"vwap_distance_pct": 4.5045,
"position_52w_pct": 44.72,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:29:36Z",
"source": "yfinance_quote",
"name": "Marker Therapeutics, Inc.",
"episode_id": "n0:MRKR:2026-10-19",
"ema_trend": "1.01 > 1.05 > 1.12",
"vwap_state": "below",
"selection_as_of": "2026-10-19T15:15:55.926875Z",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:15:55.926875+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:29:36Z",
"vwap_as_of": null
},
{
"symbol": "ATNM",
"role": "alternative",
"price": 1.32,
"base_price": 1.3501,
"return_since_base_pct": -2.2295,
"session_return_pct": 19.48,
"change_since_prior_pct": 0.0,
"volume_ratio": 1.99,
"rsi": 63.82,
"vwap": 1.29,
"vwap_distance_pct": 2.3256,
"position_52w_pct": 77.59,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:56:04Z",
"source": "yfinance_quote",
"name": "Actinium Pharmaceuticals, Inc.",
"episode_id": "n0:ATNM:2026-10-19",
"ema_trend": "1.13 > 1.13 > 1.09",
"vwap_state": "above",
"selection_as_of": "2026-10-19T15:16:17.856663Z",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T15:16:17.856663+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:56:04Z",
"vwap_as_of": null
},
{
"symbol": "INFY",
"role": "alternative",
"price": 12.2407,
"base_price": 12.275,
"return_since_base_pct": -0.2794,
"session_return_pct": 0.3336,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.48,
"rsi": 75.27,
"vwap": 12.15,
"vwap_distance_pct": 0.7465,
"position_52w_pct": 40.92,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:55:19Z",
"source": "yfinance_quote",
"name": "Infosys Limited",
"episode_id": "narrative:INFY:40115d2cb35fa2f1",
"ema_trend": "11.6 > 11.3 > 11.37",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:40Z",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:40+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:55:19Z",
"vwap_as_of": null
},
{
"symbol": "G",
"role": "alternative",
"price": 37.68,
"base_price": 37.68,
"return_since_base_pct": 0.0,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.15,
"rsi": 78.15,
"vwap": 37.36,
"vwap_distance_pct": 0.8565,
"position_52w_pct": 77.57,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:00:47Z",
"source": "yfinance_quote",
"name": "Genpact Limited",
"episode_id": "narrative:G:62d41fe65f9523e4",
"ema_trend": "35.96 > 35.14 > 34.75",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:30Z",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:30+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T21:00:47Z",
"vwap_as_of": null
},
{
"symbol": "RIGL",
"role": "alternative",
"price": 46.72,
"base_price": 47.1998,
"return_since_base_pct": -1.0165,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.19,
"rsi": 43.29,
"vwap": 46.66,
"vwap_distance_pct": 0.1286,
"position_52w_pct": 90.35,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:01Z",
"source": "yfinance_quote",
"name": "Rigel Pharmaceuticals, Inc.",
"episode_id": "narrative:RIGL:ca95148af41e4931",
"ema_trend": "47.29 > 47.31 > 45.84",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:45Z",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:18:45+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:00:01Z",
"vwap_as_of": null
},
{
"symbol": "WDAY",
"role": "alternative",
"price": 195.2,
"base_price": 193.84,
"return_since_base_pct": 0.7016,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.18,
"rsi": 55.62,
"vwap": 192.67,
"vwap_distance_pct": 1.3131,
"position_52w_pct": 78.33,
"extended_hours_pct": null,
"as_of": "2026-10-19T21:06:04Z",
"source": "yfinance_quote",
"name": "Workday, Inc.",
"episode_id": "narrative:WDAY:15757f112d8d2f99",
"ema_trend": "190.5 > 189.74 > 185.71",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:20:42Z",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:20:42+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T21:06:04Z",
"vwap_as_of": null
},
{
"symbol": "ESLT",
"role": "alternative",
"price": 759.47,
"base_price": 759.42,
"return_since_base_pct": 0.0066,
"session_return_pct": null,
"change_since_prior_pct": 0.0,
"volume_ratio": 0.57,
"rsi": 63.56,
"vwap": 754.86,
"vwap_distance_pct": 0.6107,
"position_52w_pct": 74.74,
"extended_hours_pct": null,
"as_of": "2026-10-19T20:00:12Z",
"source": "yfinance_quote",
"name": "Elbit Systems Ltd.",
"episode_id": "narrative:ESLT:ae731078c5dd8bf2",
"ema_trend": "716.16 > 710.5 > 728.89",
"vwap_state": "above",
"selection_as_of": "2026-10-19T17:18:44Z",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"day0_close": {
"status": "missing",
"market_day": "2026-10-19",
"reference_as_of": "2026-10-19T17:18:44+00:00",
"reason": "same_day_regular_close_not_captured",
"price": null,
"base_price": null,
"return_since_base_pct": null,
"as_of": "",
"available_at": "",
"source": "",
"capture_kind": "",
"source_fields_sha256": "",
"benchmark_status": "unavailable",
"benchmarks": []
},
"price_as_of": "2026-10-19T20:00:12Z",
"vwap_as_of": null
}
],
"benchmarks": [],
"coverage": {
"candidate_rows": 8,
"candidate_prices": 8,
"candidate_technical": 8,
"benchmark_rows": 0,
"day0_close_rows": 8,
"day0_close_prices": 0,
"day0_close_benchmark_rows": 0
}
}
}
],
"candidates": [
{
"symbol": "MRKR",
"name": "Marker Therapeutics, Inc.",
"exchange": "NasdaqCM",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3AMRKR&interval=60",
"score": 3,
"price": 1.1,
"change": 5.77,
"volume": 406826,
"avg_volume_3m": 88506,
"volume_ratio": 4.6,
"rsi": 50.0,
"ema_trend": "1.01 > 1.05 > 1.12",
"position_52w_pct": 44.72,
"vwap": 1.11,
"vwap_distance_pct": null,
"vwap_state": "below",
"facts": [
"The packet reports a $2.6 million FDA Orphan Products grant for the MT-601 pancreatic cancer study.",
"The recorded change was +5.77% on 4.60 times average volume, but the capture was below VWAP.",
"The supplied 20-session return was -5.0% versus +3.9% for the healthcare proxy, and the spread proxy was 716.61 basis points."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "ATNM",
"name": "Actinium Pharmaceuticals, Inc.",
"exchange": "NYSE American",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NYSE%20AMERICAN%3AATNM&interval=60",
"score": 5,
"price": 1.3501,
"change": 19.48,
"volume": 285589,
"avg_volume_3m": 143601,
"volume_ratio": 1.99,
"rsi": 63.82,
"ema_trend": "1.13 > 1.13 > 1.09",
"position_52w_pct": 77.59,
"vwap": 1.29,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The event record describes first-in-human ATNM-400 data at a conference, while the supplied company profile describes ATNM-400 as preclinical.",
"The packet does not include the actual conference data. The recorded change was +19.48% on 1.99 times average volume.",
"The active H15 positive-return model output was 42.85%; the SEC-aware model feature coverage was 73.9%, and its point-in-time validity was not established."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "INFY",
"name": "Infosys Limited",
"exchange": "NYSE",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NYSE%3AINFY&interval=60",
"score": null,
"price": 12.275,
"change": null,
"volume": 9394776.0,
"avg_volume_3m": 19515942.0,
"volume_ratio": 0.48,
"rsi": 75.27,
"ema_trend": "11.6 > 11.3 > 11.37",
"position_52w_pct": 40.92,
"vwap": 12.15,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The company announcement describes a collaboration with Truist to build a global capability center in India.",
"The packet supplies no contract value, revenue contribution or timing.",
"The recorded daily change was +0.29% on 0.48 times average volume; the supplied 20-session return was +12.72% while the Technology proxy was -4.33%."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "G",
"name": "Genpact Limited",
"exchange": "NYSE",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NYSE%3AG&interval=60",
"score": null,
"price": 37.68,
"change": null,
"volume": 311446.0,
"avg_volume_3m": 2139279.0,
"volume_ratio": 0.15,
"rsi": 78.15,
"ema_trend": "35.96 > 35.14 > 34.75",
"position_52w_pct": 77.57,
"vwap": 37.36,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The event is an Everest Group growth award; the packet does not connect it to new customers, revenue or cash flow.",
"The recorded change was +1.26% on 0.15 times average volume, despite a positive 20-session relative return."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "RIGL",
"name": "Rigel Pharmaceuticals, Inc.",
"exchange": "NASDAQ",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3ARIGL&interval=60",
"score": null,
"price": 47.1998,
"change": null,
"volume": 51397.0,
"avg_volume_3m": 275112.0,
"volume_ratio": 0.19,
"rsi": 43.29,
"ema_trend": "47.29 > 47.31 > 45.84",
"position_52w_pct": 90.35,
"vwap": 46.66,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The issuer release concerns new GAVRETO data across RET fusion-positive cancers, but the supplied packet contains no efficacy or safety values.",
"The recorded change was +2.68% on 0.19 times average volume.",
"The supplied 20-session return was +0.23% versus +3.90% for the healthcare proxy."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "WDAY",
"name": "Workday, Inc.",
"exchange": "NASDAQ",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3AWDAY&interval=60",
"score": null,
"price": 193.84,
"change": null,
"volume": 667694.0,
"avg_volume_3m": 3699137.0,
"volume_ratio": 0.18,
"rsi": 55.62,
"ema_trend": "190.5 > 189.74 > 185.71",
"position_52w_pct": 78.33,
"vwap": 192.67,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"The narrative item is Gartner recognition for Cloud ERP Finance; the packet supplies no bookings or revenue conversion from the recognition.",
"The recorded change was +1.57% on 0.18 times average volume.",
"The packet records a negative scan headline as an unverified conflict and 30-day net insider sales equal to 0.31% of float."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
},
{
"symbol": "ESLT",
"name": "Elbit Systems Ltd.",
"exchange": "NASDAQ",
"tradingview_url": "https://es.tradingview.com/chart/?symbol=NASDAQ%3AESLT&interval=60",
"score": null,
"price": 759.42,
"change": null,
"volume": 48104.0,
"avg_volume_3m": 85048.0,
"volume_ratio": 0.57,
"rsi": 63.56,
"ema_trend": "716.16 > 710.5 > 728.89",
"position_52w_pct": 74.74,
"vwap": 754.86,
"vwap_distance_pct": null,
"vwap_state": "above",
"facts": [
"Trusted reporting describes a $235 million European defense contract, and the packet includes a same-day SEC 6-K filing record.",
"The recorded change was +0.53% on 0.57 times average volume; the capture was above VWAP.",
"The supplied 20-session return was +1.16% versus -1.71% for the Industrials proxy. Delivery schedule, margin and backlog contribution are absent."
],
"role": "alternative",
"selected": false,
"reason": "not_selected"
}
],
"news": [
{
"title": "SEC 8-K filing",
"url": "https://www.sec.gov/Archives/edgar/data/764065/000076406526000112/clf-20261019.htm"
}
],
"transcript_url": null,
"initial_transcript_anchor": "transcript-entry-e7c501bf18bac3d323a27cd7aae71e24a3a06f6da2999793f5d7ba94e1e271d1",
"chart_url": null,
"secondary_chart_url": null,
"forecast_chart_url": null,
"methodology_url": "https://trydingday.com/methodology/",
"track_record_url": "https://trydingday.com/track-record/",
"market_timezone": "America/New_York"
}
}